R
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
Ireland
Recent Filings
- 8-K189.7 KBRVL Pharmaceuticals plcFeb 13, 4:05 PM ET·0001104659-24-019866
- 8-K189.5 KBRVL Pharmaceuticals plcJan 17, 4:05 PM ET·0001104659-24-004463
- 8-K195.6 KBRVL Pharmaceuticals plcDec 20, 4:15 PM ET·0001104659-23-127735
- SC 13D/A132.7 KBRVL Pharmaceuticals plcNov 27, 9:24 PM ET·0001193125-23-283535
- 8-K51.7 MBRVL Pharmaceuticals plcNov 27, 4:06 PM ET·0001104659-23-121234
- SC 13D/A72.4 KBRVL Pharmaceuticals plcNov 1, 4:27 PM ET·0001171843-23-006596
- 8-K194.0 KBRVL Pharmaceuticals plcSep 22, 4:05 PM ET·0001104659-23-103183
- 8-K196.0 KBRVL Pharmaceuticals plcSep 5, 4:06 PM ET·0001104659-23-098234
- SC 13D157.9 KBRVL Pharmaceuticals plcSep 5, 7:45 AM ET·0001193125-23-228094
- 10-K11.9 MBRVL Pharmaceuticals plcMar 20, 5:19 PM ET·0001558370-23-004211
Insiders
10- Altchem Ltd10% Owner
- Avista Capital Partners III GP, L.P.10% Owner
- Burgstahler David FDirector, 10% Owner
- COWAN GREGORY LDirector
- DeBiasi Michael J.Director
- deVries Tina MarieEVP, Research & Development
- Einhorn Andrew J.Chief Financial Officer
- Harsaul Foundation10% Owner
- Klein ChristopherGeneral Counsel & Secretary
- Lask AlisaDirector
Tickers
No tickers on record
Addresses
business
400 CROSSING BOULEVARD
BRIDGEWATER, NJ, 08807
mailing
400 CROSSING BOULEVARD
BRIDGEWATER, NJ, 08807
Former Names
- Osmotica Pharmaceuticals plc2022-01-18
- Osmotica Pharmaceuticals Ltd2018-08-22